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Handheld high-throughput plasmonic biosensor using
computational on-chip imaging
Arif E Cetin1*, Ahmet F Coskun2,3*, Betty C Galarreta1,4, Min Huang1, David Herman2, Aydogan Ozcan2,6
and Hatice Altug1,5
We demonstrate a handheld on-chip biosensing technology that employs plasmonic microarrays coupled with a lens-free
computational imaging system towards multiplexed and high-throughput screening of biomolecular interactions for point-of-care
applications and resource-limited settings. This lightweight and field-portable biosensing device, weighing 60 g and 7.5 cm tall,
utilizes a compact optoelectronic sensor array to record the diffraction patterns of plasmonic nanostructures under uniform
illumination by a single-light emitting diode tuned to the plasmonic mode of the nanoapertures. Employing a sensitive plasmonic
array design that is combined with lens-free computational imaging, we demonstrate label-free and quantitative detection of
biomolecules with a protein layer thickness down to 3 nm. Integrating large-scale plasmonic microarrays, our on-chip imaging
platform enables simultaneous detection of protein mono- and bilayers on the same platform over a wide range of biomolecule
concentrations. In this handheld device, we also employ an iterative phase retrieval-based image reconstruction method, which
offers the ability to digitally image a highly multiplexed array of sensors on the same plasmonic chip, making this approach
especially suitable for high-throughput diagnostic applications in field settings.
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INTRODUCTION
Early detection and effective diagnosis are important for disease
screening and preventing epidemics. Most of the current medical
technologies are time-consuming and require costly chemical proce-
dures and bulky instrumentation, necessitating an advanced medical
infrastructure and trained laboratory professionals. In developing
countries, there is an urgent need for cost-effective and easy-to-use
diagnostics technologies. Similarly, in developed countries, even
though resources are available, the cost of health care is still a concern.
For various diseases including Alzheimer’s disease and cancer,
expression of certain proteins in the body is up- or downregulated,
making them suitable to be used as disease biomarkers. Recent works
have also shown that instead ofmonitoring a single biomarker, screen-
ing a panel of proteins could significantly improve the accuracy in
medical diagnostics by eliminating false positives.1–3 High-through-
put sensing technologies that can enable simultaneous detection of a
wide range of proteins might offer a viable solution for medical diag-
nosis. Therefore, there is a strong need for affordable and high-
throughput screening technologies that can effectively monitor and
diagnose various medical conditions. As recognition of some of these
challenges, international consortiums are calling for innovative solu-
tions toward cost-effective and handheld wireless biosensor devices
with a desired list of performance metrics (see, for example, The
Qualcomm Tricorder X Prize and Nokia Sensing X Challenge).
Similarly, various point-of-care diagnostic devices have been
developed4–29 and among them optical imaging and sensing tech-
niques are highly advantageous as they can provide real-time, high-
resolution and highly sensitive quantitative information, potentially
assisting rapid and accurate diagnosis.30–40 To date, a number of
optical techniques have been proposed for point-of-care diagnostics
such as in vitro optical devices,41–53 including portable optical imaging
systems, optical microscopes integrated to cell phones or in vivo
optical devices,54–63 involving confocal microscopy, microendoscopy
and optical coherence tomography techniques. Among these
approaches, lens-free computational on-chip imaging64 has been an
emerging technique that can eliminate the need for bulky and costly
optical components while also preserving (or even enhancing in cer-
tain cases) the image resolution, field of view and sensitivity. In this
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on-chip microscopy platform, computational holographic recon-
struction and phase recovery methods are used to partially eliminate
diffraction effects, providing higher resolution microscopic images
across very large imaging areas, e.g.,.20–30 mm2 using off-the-shelf
CMOS (Complementary Metal–Oxide–Semiconductor) imager
chips.65,66 Together with the improvements provided by unique sam-
ple preparation and self-assembly techniques, lens-free on-chip
imaging can even detect single viruses and sub-100 nm particles67,68
across a wide field of view, e.g., .20 mm2 and provides a high-
throughput nano-imaging platform.
In parallel to these advancements in computational imaging, current
trends for health-care technologies aim to utilize high-throughput and
massively multiplexed detection methods that can be used to rapidly
extract a wide range of diagnostic data.69–73 One way of such multi-
plexing is fluorescence imaging.74–76 However, this approach suffers
from cross-interference of labels with other molecular binding inter-
actions, a limited number of fluorophore labels and additional labeling
steps that increase the sample preparation time. Recently, various
high-throughput optical detection methods have been investigated to
overcome these problems as they offer strong advantages by being
compatible with physiological solutions, not affected by the variation
in the ionic strengths of biosolutions, and reducing sample contami-
nation via allowing remote transduction of the biomolecular binding
signal.77–85 Among optical biosensors, surface plasmon resonance
(SPR)-based platforms are one of the most favored. Surface plasmons
(SPs) are waves propagating at a metal/dielectric interface associated
with the collective electron oscillations. This feature makes SPs highly
suitable for investigation of near-field variations of a specimen due to
absorption of specific molecules onto the metal surface, enabling label-
free detection of binding events.86–88 In fact, SPR is considered as the
gold standard for label free biodetection. Strong sensitivities of SPR
sensors allow detection of small proteins with molecular weights down
to tens of kDa.89,90 As gold is highly biocompatible, SPR sensors also
enable robust surface chemistry and biofunctionalization necessary for
specific detection of target biomolecules. However, multiplexing capa-
bility of conventional SPR sensors is limited in field settings due to the
alignment sensitive prism coupling scheme and bulky instrumentation.
These requirements pose major obstacles in achieving handheld diag-
nostics and health-care technologies. Recently, nanoplasmonics has
taken significant attention as it can potentially overcome these chal-
lenges.91–94 Nanoscale plasmonic structures consisting of metallic par-
ticles and/or apertures provide new avenues for biosensing and
spectroscopy due to their ability to generate dramatic field enhance-
ments and spatially confine light on the nanometer scale.95–103 In
particular, nanoaperture arrays support extraordinary optical trans-
mission through the exploitation of plasmonic modes excited by the
grating orders of the array.104,105 These plasmonic modes are highly
sensitive to minute changes in the near-field refractive index of the
nanoaperture.91–94 In addition, this grating configuration allows
excitation light to be coupled to the SP waves even at normal incidence.
This collinear configuration is naturally compatible for imaging within
an array format, making it a competitive candidate for high-through-
put sensing and diagnostics applications.106
In this letter, we introduce an integrated system that combines
wide-field plasmonic arrays with lens-free computational on-chip
imaging enabling a high-throughput and handheld label-free sensing
device. Our lens-free computational platform utilizes a CMOS imager
chip to record the diffraction patterns of the plasmonic structures
without the use of any lenses under uniform illumination by a single
light-emitting diode (LED) tuned to the plasmonic modes of the
nano-apertures. In this system, the plasmonic sensor chip, the LED-
based excitation source and the compact CMOS image sensor are
automatically aligned in a dark environment, without the need for
any bulky optical instruments or mechanical microstages. Unlike
existing multiplexed biodetection systems, this on-chip biosensing
technology is ultracompact and light-weight (,7.5 cm tall and 60
g), making it highly suitable for field medicine and diagnostic needs.
Our biosensor detects protein monolayers down to 3 nm thickness
without any labels and enables quantitative analysis of protein binding
events over a wide range of biomolecule concentrations. The multi-
plexing capability of our lens-free computational sensing system is
demonstrated by simultaneous identification of protein mono- and
bilayers on the same plasmonic chip. Employing a computational
image reconstructionmethod that is based on iterative phase retrieval,
our device provides a promising platform for high-throughput bio-
sensing of for example over 150 000 sensors on large-scale plasmonics
chip through a CMOS imager with an active area of 5.7 mm34.3 mm.
As shown in Figure 1a and 1b, our on-chip plasmonic biosensing
platform is comprised of the following components: (i) a plasmonic
chip containing microarray pixels composed of periodic nanoholes
fabricated on a thin gold film to detect the variations in the surface
conditions (near-field) due to the specific binding of molecules on the
chip surface. Scanning electron microscope (SEM) image of 6 plasmo-
nic sensor pixels containing nanohole arrays is provided in Figure 1c;
(ii) an LED source that significantly overlaps with the plasmonic modes
of the nanostructured surface of the chip. These plasmonic nanohole
arrays, when illuminated by an LED (peak wavelength:,683 nm, band-
width:,26 nm), excite a plasmonic mode which supports electromag-
netic fields strongly localized around the rims of the nanoholes at the
top surface. The fields extend into the sensing medium, together with
,550 times intensity enhancement of as verified by our finite-difference
time-domain simulation (FDTD) results shown in Figure 1d (see
Supplementary Information for details); and (iii) a CMOS imager chip
that records the diffraction patterns of the plasmonic nanoapertures,
modulated by molecular binding events on the aperture surface. Design
and fabrication details of this platform are presented in the next section,
which is then followed by the section on ‘results and discussion’.
MATERIALS AND METHODS
The presented computational biosensing platform combines wide-
field nanoplasmonic arrays with a lens-free on-chip imaging, where
a CMOS imager chip records the diffraction patterns of the plasmonic
structures without the use of any lenses under uniform illumination
provided by a LED that overlaps with the plasmonic modes of the
nanoapertures. Integrating the plasmonic sensor chip, the LED-based
excitation source and the compact image sensor in a lightweight hand-
held unit, this biosensor platform can monitor multiple protein bind-
ing events without any labels at the point of care or in field settings.
Design of the wide-field plasmonic microarrays
In our platform, we utilize microarray pixels composed of nanoaper-
tures in the form of nanohole arrays exhibiting multiple spectral points
of extraordinary light transmission due to the excitation of SP waves at
different grating orders (see Supplementary Information for the theory
of the SP excitation through periodic structures and Supplementary
Fig. S1 for the fabrication of nanohole arrays).106–111 For our analysis,
we focus on the SP(21,0) mode (indicated by a black arrow in experi-
mental spectrum taken by an optical spectrum analyzer shown in
Figure 2a), since it supports large transmission intensity which can be
easily detected by our lens-free imaging device. Inset in Figure 2a shows
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the calculated distribution of the y-component of the magnetic field
intensity, (jHyj2). Here, the standing field pattern along the x-direction
is due to the propagating SP excitation and the hot spots around the
rims of the nanoholes along the y-direction are due to the localized SP
waves.112,113 For the SP(21,0) mode, the local excitations have dipolar
character allowing the light to strongly couple to localized SPs resulting
in an extraordinary light transmission. Localized SPs also lead to large
near-field enhancements around the nanoapertures. Accordingly, our
plasmonic aperture system shows high sensitivities to surface condi-
tions by enabling strong overlap between analytes in the vicinity of the
sensor surface (near-field) and the local fields. Upon biofunctionaliza-
tion of the microarray pixels with a protein bilayer, containing
0.5 mg mL21 protein A/G and 0.5 mg mL21 protein IgG, which
increases the local refractive index around the sensor surface, the plas-
monic mode shifts to longer wavelengths by,19 nm (from 683 nm to
702 nm).91,92 Protein A/G is a recombinant fusion protein constituting
binding domains of proteins A and G. Protein A/G has a molecular
weight of 50.46 kDa and the thickness of protein A/G layer is approxi-
mately 3 nm.93 Protein IgG is immobilized on protein A/G due to the
high affinity of protein A/G to the Fc regions of protein IgG. Molecular
weight of protein IgG is 160 kDa and the thicknesses of this layer is
approximately 5 nm (see Supplementary Information for methods on
protein chemistry and sample preparation techniques).
Characterization of the lens-free on-chip sensing platform
In our lens-free plasmonic sensing platform, the spectral shift in res-
ponse to molecular binding is determined bymonitoring the intensity
changes captured by the CMOS imager (Figure 1). In order to reliably
detect the red shift in the transmission resonance, the selection of the
LED peakwavelength is critical, and it should ideallymatch to 683 nm.
As shown in Figure 2c, our LED response spectrally overlaps with the
transmission resonance of the nanohole array located at 683 nm.
Figure 2b illustrates that the presence of the protein binding events
leads to a redshift in the transmission resonance, detuning it from
the LED peak wavelength. Consequently, the total transmitted signal
of the acquired lens-free image drops considerably; thus enabling to
detect presence of biomolecular layers with a thickness down to 3 nm
(refer to the section on ‘results and discussion’ for further details).
In our on-chip detection platform, the vertical distance between the
plasmonic microarray pixel (with an individual pixel size of
100 mm3100 mm) and the CMOS active area is ,1 mm. Therefore,
even if the plasmonic interaction occurs in the near-field of the sensor
chip, evanescent wave contribution is negligible during the detection
or sampling of the lens-free diffraction patterns of the nanoapertures.
For an accurate calculation for the diffraction pattern, we utilize an
approach based on convolution and Fresnel kernel (see Figure 2d and
Supplementary Fig. S2 for details of the field transmission calculations
a
c
b
Battery
Plasmonic chip
CMOS
450
400
350
300
250
200
150
100
50
500
Transmission of the
plasmonic chip
Au
SiN
Ti
0
LED
illumination
dPlasmonic substrate
100 mm 1 mm
Figure 1 On-chip sensing platformwith plasmonicmicroarrays and lens-free computational imaging. (a) Real picture of the portable biosensing device, weighing 60 g
and 7.5 cm tall designed for point-of-care applications. In the picture, the hand of the author highlights the compactness of the device. (b) Schematic of the on-chip
computational biosensing platform comprising a battery, an LED, a plasmonic chip and a CMOS imager chip. (c) SEM image of 6 plasmonic sensor pixels of size
100 mm3100 mm (the distance between plasmonic pixels are 100 mm) and the zoomed image of a plasmonic pixel containing periodic nanohole array. The diameter of
the aperture is 200 nm and the period of the array is 600 nm. (d) FDTD simulation of the near-field intensity enhancement distribution ( | E | 2/ | E0 |
2) for the nanohole
array calculated at the peak wavelength of the LED spectrum. The nanohole apertures are fabricated through 120 nm thick gold, 5 nm thick titanium and 80 nm thick
silicon nitride layers. FDTD, finite-difference time-domain; LED, light emitting diode; SEM, scanning electron microscope.
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through our plasmonic chip).114 It is also important to note that since
we utilize circular-shape apertures which have azimuthal symmetry in
the aperture plane, the transmission response is the same for different
linear polarization components (see Supplementary Fig. S3 for the
near-field analysis of polarized vs. unpolarized light sources for our
nanoaperture design). This behavior is highly advantageous for our
lens-free computational detection system since a simple LED without
a polarizer can be used for partially coherent illumination of the
nanoaperture plane.
Computational reconstruction method for multiplexed plasmonic
microarrays
To get multiplexed and high-throughput read-out, using a large
number of sensor pixels into the same chip area results in a signifi-
cant spatial overlap of diffraction patterns at the detector plane due
to the lens-free operation. As illustrated in Figure 3a, the transmit-
ted fields propagate ,1 mm before being captured by the CMOS
imager chip. To address this spatial overlap problem for especially
high-density microarrays, we employ a numerical approach that is
based on a phase recovery technique65 to digitally backpropagate
the diffraction patterns onto the exit aperture of the nanohole
array.114 We should emphasize that even using an LED, the spatial
coherence diameter at the sensor chip surface can be fine-tuned
between 0.2 mm and 1 mm by for example adjusting the vertical
distance between the LED and sensor chip or changing the pinhole
diameter in front of the LED. This partial spatial coherence ensures
that each element of the plasmonic microarray effectively faces a
quasimonochromatic and spatially coherent plane wave, such that
we can frame the entire reconstruction process around phase recov-
ery. The workflow of our iterative phase retrieval method
(Figure 3b) can be summarized as follows: (i) lens-free diffraction
images of the plasmonic microarrays are recorded using a CMOS
imager chip; (ii) the raw diffraction images are then upsampled
typically by a factor of 4–6, using cubic spline interpolation method
before the iterative reconstruction procedure. Note that this upsam-
pling step does not increase the information content of the diffrac-
tion images; however, it helps to achieve faster phase recovery; (iii)
the square root of the diffracted field intensity, calculated from
upsampled lens-free images, is propagated back to the nanoaperture
plane with an initial guess of zero phase. The object support (which
is known a priori due to the precise fabrication of the aperture
array) is then enforced at the nanoaperture plane by thresholding
the intensity of the field, where the complex field outside the sup-
port is replaced with a uniform background intensity value. Next,
the modified field at the nanoaperture plane is propagated back to
the detector plane, creating a complex field with a non-zero two-
dimensional phase function. The amplitude of this complex field is
replaced with the square root of the original recorded diffraction
field intensity while leaving the new phase function untouched.
After repeating this iterative process with approximately N of
,15 cycles, the two-dimensional phase of the diffracted field incid-
ent on the detector array can be iteratively recovered from a single
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Figure 2 Working principle of our on-chip computational biosensing platform. (a) Experimental transmission spectra of the bare nanohole array (black solid line) and
the plasmonic substrate covered with protein bilayer containing 0.5 mg mL21 A/G and 0.5 mg mL21 IgG (red solid line). (Inset) FDTD simulation result showing the
intensity distribution of the y-component of the magnetic field ( | Hy |
2) calculated for a bare aperture array at 683 nm. (b) 3D intensity plot of the experimental
transmission signal and (inset) corresponding diffraction patterns of a plasmonic microarray pixel before and after the addition of the protein bilayer acquired by the
CMOS imager. (c) Spectral curve demonstrating the overlap of the LED spectrum (blue dashed line) and the transmission response of the bare nanohole array (black
solid line) measured by an optical spectrum analyzer. (d) 3D intensity plot of the simulated transmission pattern for the bare and the biofunctionalized nanohole array
calculated at a propagation distance of 1 mm from the nanohole array structure to the sensor plane at the peak wavelength of the LED spectrum. CMOS,
Complementary Metal–Oxide–Semiconductor; 3D, three-dimensional; FDTD, finite-difference time-domain; LED, light-emitting diode.
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intensity image;65 and (iv) this complex field can then be backpropa-
gated to the object/aperture plane, providing the reconstructed images
of the plasmonic microarrays at the nanoaperture plane. To dem-
onstrate the success of the above outlined phase recovery-based image
reconstruction process, Figure 3c illustrates the diffraction patterns of
six different neighboring plasmonic sensor pixels (separated by 25 mm
edge-to-edge distance) that are detected by the CMOS imager chip at a
propagation distance of 2 mm from the nanostructures to the sensor
plane, exhibiting partial spatial overlaps due to our lens-free operation.
Employing the iterative reconstruction procedure discussed above, the
diffracted lens-free images of the plasmonic sensor pixels can now be
digitally focused onto the nanoaperture plane, removing the spatially
overlapping parts of these images. This lens-free image reconstruction
process is quite valuable especially for highly dense arrays of nanoaper-
tures for increased multiplexing. However, we should also note that
quantitative sensing information of the binding events could also be
extracted from only the diffraction patterns of the same nanoapertures
in case the physical separation between neighboring aperture regions is
large, minimizing the intensity overlap at the detector/sampling
plane.66 Using this phase recovery approach procedure, we can reduce
the distance between individual sensory pixels even down to 2 mm.66 A
single sensor with a size of 10 mm310 mm, consisting of more than 200
nanoholes (hole diameter5200 nm and array period 600 nm) should
result in sufficient transmitted signal to be captured by the CMOS
imager.84 Based on these numbers, employing a CMOS imager with
an active area of 5.7 mm34.3 mm, we could image 170 000 sensor
pixels all in parallel, which is highly promising for high-throughput
applications.
RESULTS AND DISCUSSION
Multiplexing performance of the lens-free detection platform
To evaluate the performance of our computational biosensing plat-
form, we demonstrate multiplexed detection of protein mono- and
bilayers. Figure 4a and 4b show the schematic view and the diffraction
patterns of the analyzed microarray pixels, respectively. Here, the
microarray pixels enumerated from ‘1’ to ‘6’ correspond to the bare
sensors, and ‘M’ and ‘B’ correspond to the same sensors after intro-
ducing protein monolayer (M) containing bovine serum albumin
(BSA, 0.5% v/v), and protein bilayer (B) containing 0.5 mg mL21
protein A/G and 0.5 mg mL21 protein IgG, respectively.91–94,115
Here, approximately 150 pL protein solution is precisely introduced
on the individual sensor pixel using a protein nanospotter.115 BSA has
a molecular weight of 66 kDa and forms a very thin layer on our
plasmonic substrate, approximately 3 nm.116,117 Figure 4c shows the
transmission spectrum of our nanohole array before and after the
presence of the protein layers. Initially, for the 6 bare pixels, the plas-
monicmode has an average resonance wavelength of,690.3 nm, with
a standard deviation (s.d.) of 0.74 nm. For the 3 pixels that are covered
with protein monolayer, the plasmonic mode shifts to 696.5 nm
(s.d.50.21 nm) and for the remaining 3 pixels with protein bilayer,
it shifts to 707.4 nm (s.d.50.77 nm). As clearly seen by the lens-free
diffraction pattern images in Figure 4b, monolayer spotted sensors
look brighter than the bilayer spotted ones due to the additional
11 nm shift from the LED peak wavelength. Figure 4d shows the
statistical analysis of our plasmonic pixels, demonstrating a good cor-
relation between the resonance wavelength shift and the relative
intensity difference corresponding to mono- and bilayers.
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Figure 3 Numerical technique for the reconstruction of the diffraction images through a phase retrieval method. (a) Illustration of the partially overlapping diffraction
patterns of the dense plasmonic microarrays at the detector/sampling plane due to our lens-free operation. (b) Workflow of the reconstruction procedure based on an
iterative phase recovery algorithm. (c) Partially overlapping diffraction patterns of six different neighboring plasmonic microarray pixels, separated by 25 mm edge-to-
edge distance, acquired by the lens-free imager at a propagation distance of 2 mm from the nanostructures to the sensor plane. The reconstructed images of the
microarray pixels using the phase retrieval approach are also presented.
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Quantitative analysis of binding events using lens-free on-chip
detection
Our on-chip plasmonic biosensing platform can also be utilized for
quantitative analysis of binding events, providing precise concentra-
tion of target biomolecules bound to the plasmonic substrates.
Towards this end, we demonstrate the quantification of a single-type
of protein in a large variety of concentrations, spanning from micro-
gram per milliliter to milligram per milliliter range. Furthermore, we
image reference and target plasmonic microarray pixels simulta-
neously on the same chip to quantify the binding events on the target
sensors, engineering a robust self-calibrated biodetection system that
operates independent of the LED intensity variations from measure-
ment to measurement. To illustrate this, Figure 5a shows lens-free
diffraction patterns of six different sensors where (i) the pixels denoted
by ‘M’ are the reference sensors and their spectral responses stay con-
stant through the whole concentration experiment; and (ii) the pixels
denoted by ‘B’ are the target sensors used for our concentration ana-
lysis. In these measurements, reference sensors are initially covered
with BSA to block nonspecific binding events on these pixels, and the
target sensors are covered with protein A/G (,4 mg mL21) for cap-
turing protein IgG on the sensor surface. In more complex sample
matrices, custom designed blocking agents can also be used, in a
similar fashion, to reduce nonspecific molecular bindings. Note that
the BSA and A/G pixels provided comparable level of spectral shift and
transmitted signal intensity, indicating that similar amount of biomass
bound to the reference and target pixels. Target pixels have then been
processed with 8 different IgG concentrations, ranging from
3.9 mg mL21 to 1000 mg mL21. Figure 5b shows the average spectral
response, measured by an optical spectrum analyzer, of the reference
and the target sensors for different protein concentrations de-
monstrating that the plasmonic mode consistently shifts to longer
wavelengths as the concentration increases. The statistical analysis
calculated from the optical spectrum analyzer measurements in
Figure 5c shows that the difference in the average resonance shift value
for the target pixels spanning a range from 2.95 nm to 27.1 nm. In the
figure inset, we show the relationship between the spectral shift in the
plasmonic mode and the IgG concentration. In the low concentration
range (e.g., 3.9–100 mg mL21), the plasmonic mode red-shifts linearly
with increasing IgG concentration, whereas it shows minor variations
at high concentrations (250–1000 mg mL21) due to saturation of
binding sites. Calculated from the lens-free images, the corresponding
intensity difference analysis in Figure 5d reveals aminimumdetectable
intensity difference of 0.024 (a.u.) as denoted by the red curve which
corresponds to aminimum detectable wavelength shift of 3 nm for the
transmission resonance from its initial position. Note that this 3 nm
limit of detection can also be converted into a refractive index sen-
sitivity of 621 nm RIU21, corresponding to a minimum detectable
refractive index change of ,431023 RIU (see Supplementary
Figs. S4 and S5 for the same analysis conducted using an optical
spectrum analyzer). These results summarized in Figures 4 and 5
confirm that our plasmonic biosensing approach is highly promising
for simultaneous detection of different biomolecules over a wide range
of concentrations using the same field-portable and cost-effective
handheld platform.
The presented computational high-throughput biosensing plat-
form lends itself to a light-weight and compact point-of-care diag-
nostic tool that can potentially provide real-time results without the
need for any trained professionals. Although such on-chip sensing
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Figure 4 Multiplexing capability of the on-chip computational biosensing platform. (a) Schematic view and (b) the lens-free diffraction patterns of six different
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platform holds promise as a field-deployable and cost-effective hand-
held diagnostics device, especially for developing countries, it is
important to note that our lens-free imaging platform has relatively
higher detection limits (in the order of,mgmL21) compared to other
plasmonic sensing approaches such as conventional SPR-based plat-
forms. In order to systematically improve our detection limits (down
to ng mL21) we can explore several avenues: (i) spectrally narrow
chip-based optoelectronic excitation sources, e.g., laser diodes or res-
onant-cavity enhanced LEDs can be employed to determine the min-
ute spectral variations in the plasmonicmodes; (ii) superior plasmonic
designs achieving much sharper plasmonic resonances with stronger
near-field enhancements, such as Fano resonant structures,94,118,119
can be implemented; (iii) the spectral shifts in the transmission res-
onance of the nanoapertures can be more sensitively tracked by
acquiring multiple lens-free images (i.e., each with a different color
LED). These lens-free frames can then be digitally merged, producing
higher contrast differences between the reference and target images;84
(iv) better CMOS/CCD imagers, equipped with cooling circuits, can
be employed in this plasmonic sensing platform achieving higher
sensitivities; (v) advanced computational reconstruction approaches,
e.g., based on convex optimization,120–123 can be applied to the dif-
fraction images of the plasmonic chips; and (vi) nanoparticle based
assays can be also functionalized on the same plasmonic substrates
improving the binding sites of biomolecules, and further enhancing
the contrast of the low-density biomolecules detected through
improved lens-free diffraction patterns. A major advantage of using
nanoparticles in this on-chip biosensing platformwould be to increase
the near-field interactions between the biomolecules and the surface
plasmon waves up to the penetration depth of evanescent waves (,
200 nm). In our current plasmonic biosensing work, the binding
events occur on a planar plasmonic substrate, limiting the near-field
interactions only to the surface of the gold layer. Therefore, nano-
particles with diameters of 200–300 nm could provide additional
three-dimensional binding sites, increasing the interactions of the
biomolecules and surface plasmons. The proof of concept of such an
approach is already illustrated in Supplementary Figs. S6 and S7,
where streptavidin-coated nanoparticles bound to the plasmonic sub-
strates can be detected using our on-chip biosensing platform, creating
an enhanced contrast of the lens-free diffraction images after the
binding events. Using a systematic investigation of the avenues
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Figure 5 Quantification of a single-type protein concentration. (a) Lens-free diffraction patterns of the 2 reference and 4 target plasmonic microarray pixels are
analyzed on the same chip to quantify the binding events on the target sensors, where reference and target sensors are coveredwith proteinmonolayers (M) containing
BSA and protein bilayers (B) containing A/G and IgG, respectively. (b) Spectral response of the plasmonic sensors functionalized with different protein IgG con-
centrations, ranging from 3.9 mg mL21 to 1000 mg mL21. Statistical analysis of (c) the peak wavelength shift in the plasmonic mode calculated from the optical
spectrum analyzer measurements (figure inset: resonance shift in the plasmonic mode vs. IgG concentration) and (d) the corresponding intensity difference analysis
determined from our lens-free images (figure inset: zoomed figure showing the detection limit). Aminimumdetectable intensity difference of 0.024 (a.u.), indicated by
a red line, can be calculated by adding twice the standard deviation to themean intensity difference value of the reference sensor containingBSA,which corresponds to
a minimum detectable wavelength shift of 3 nm. BSA, bovine serum albumin.
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discussed above, the detection limits of our computational plasmonic
sensing platform can be improved down to ng mL21 range while still
keeping the entire platform compact, light-weight, cost-effective and
high-throughput for field medicine and point-of-care diagnostics.
CONCLUSIONS
In conclusion, we have demonstrated an on-chip computational bio-
sensing approach that uniquely integrates plasmonic microarrays and
a lens-free computational microscopy platform towards label-free,
high-throughput and multiplexed detection of ultrathin layers of bio-
molecular binding events. This cost-effective and portable biosensing
device weights 60 g and employs an off-the-shelf CMOS imager to
record the lens-free diffraction patterns of plasmonic nanoaperture
arrays that are illuminated by a quasimonochromatic plane wave from
an LED which is tuned to the plasmonic resonances. Combining a
sensitive plasmonic microarray substrate and lens-free computational
imaging, our on-chip biosensing device can detect biomolecules with
protein layer thicknesses down to ,3 nm. The presented computa-
tional biosensing approach, integrating large-scale plasmonic micro-
arrays, could be especially useful for simultaneous detection of a large
number of biomolecular interactions in field settings without the use
of any bulky and costly instruments, creating a compact and high-
throughput handheld technology for point-of-care and telemedicine
applications.
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